Novo CEO pressed by Senate to chop prices of weight problems, diabetic issues medication CEO Lars Fruergaard Jørgensen told lawmakers the corporation would look at new talks with insurers regarding the record costs of Wegovy and copyright whenever they pledge to keep the medicines on their formularies.This strategy aligns with People attemp… Read More